Beam Therapeutics Inc. (BEAM)
After hours:
| Previous close | 48.79 |
| Open | 46.98 |
| Bid | 46.65 x 800 |
| Ask | 50.86 x 1000 |
| Day's range | 46.30 - 49.30 |
| 52-week range | 27.77 - 80.00 |
| Volume | |
| Avg. volume | 838,327 |
| Market cap | 3.414B |
| Beta (5Y monthly) | 1.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.59 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 77.69 |
- Simply Wall St.
Shareholders in Beam Therapeutics (NASDAQ:BEAM) are in the red if they invested a year ago
Beam Therapeutics Inc. ( NASDAQ:BEAM ) shareholders should be happy to see the share price up 16% in the last month...
- Motley Fool
5 Top Stocks for February
The Nasdaq Composite has surged over 11% so far this month as growth stocks retake center stage. Shopify (NYSE: SHOP), the Vanguard Growth ETF (NYSEMKT: VUG), Nio (NYSE: NIO), Beam Therapeutics (NASDAQ: BEAM), and Roku (NASDAQ: ROKU) have that kind of potential. Here's what makes each company a great buy now, according to five Motley Fool contributors.
- Motley Fool
3 Great Growth Stocks Down 20% or More to Buy Now
Three Motley Fool contributors were asked to identify great growth stocks down 20% or more to buy now. Here's why they chose Beam Therapeutics (NASDAQ: BEAM), Maravai LifeSciences (NASDAQ: MRVI), and Novavax (NASDAQ: NVAX). Keith Speights (Beam Therapeutics): Beam Therapeutics was flying high in the early part of 2021.
